Carcinogenesis mechanisms of Fusobacterium nucleatum

被引:125
|
作者
Gholizadeh, Pourya [1 ,2 ]
Eslami, Hosein [3 ]
Kafil, Hossein Samadi [4 ,5 ]
机构
[1] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[3] Tabriz Univ Med Sci, Dent & Periodontal Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Infect & Trop Med Res Ctr, Tabriz, Iran
[5] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
关键词
Fusobacterium nucleatum; Mechanisms; Oral cavity cancer; Pancreatic cancer; Colorectal cancer; MELANOMA INHIBITORY-ACTIVITY; GINGIVAL EPITHELIAL-CELLS; MOBILITY GROUP BOX-1; TUMOR PROGRESSION; ORAL-CANCER; RECEPTOR; IMMUNE; ACTIVATION; INFECTION; FADA;
D O I
10.1016/j.biopha.2017.02.102
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Transformed cells of cancers may be related to stromal cells, immune cells, and some bacteria such as Fusobacterium nucleatum. This review aimed to evaluate carcinogenesis mechanisms of Fusobacterium spp. in the oral cavity, pancreatic and colorectal cancers. These cancers are the three of the ten most prevalence cancer in the worldwide. Recent findings demonstrated that F. nucleatum could be considered as the risk factor for these cancers. The most important carcinogenesis mechanisms of F. nucleatum are chronic infection, interaction of cell surface molecules of these bacteria with immune system and stromal cells, immune evasion and immune suppression. However, there are some uncertainty carcinogenesis mechanisms about these bacteria, but this review evaluates almost all the known mechanisms. Well-characterized virulence factors of F. nucleatum such as FadA, Fap2, LPS and cell wall extracts may act as effector molecules in the shift of normal epithelial cells to tumor cells. These molecules may provide new targets, drugs, and strategies for therapeutic intervention. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:918 / 925
页数:8
相关论文
共 50 条
  • [21] Fusobacterium nucleatum and Colorectal Cancer
    Li, Rongrong
    Shen, Jilu
    Xu, Yuanhong
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 1115 - 1120
  • [22] Fusobacterium nucleatum empyema necessitans
    Hockensmith, ML
    Mellman, DL
    Aronsen, EL
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) : 1596 - 1598
  • [23] FUSOBACTERIUM-FUSIFORME AND NUCLEATUM
    GUILLERMET, F
    ANNALES DE MICROBIOLOGIE, 1980, B131 (01): : 95 - 96
  • [24] FUSOBACTERIUM-NUCLEATUM PERICARDITIS
    TRUANT, AL
    MENGE, S
    MILLIORN, K
    LAIRSCEY, R
    KELLY, MT
    JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 17 (02) : 349 - 351
  • [25] Fusobacterium nucleatum dissemination by neutrophils
    Ellett, Felix
    Kacamak, Nazli I.
    Alvarez, Carla R. R.
    Oliveira, Eduardo H. S.
    Hasturk, Hatice
    Paster, Bruce J. J.
    Kantarci, Alpdogan
    Irimia, Daniel
    JOURNAL OF ORAL MICROBIOLOGY, 2023, 15 (01)
  • [26] FUSOBACTERIUM-NUCLEATUM SUBSP FUSIFORME SUBSP NOV AND FUSOBACTERIUM-NUCLEATUM SUBSP ANIMALIS SUBSP NOV AS ADDITIONAL SUBSPECIES WITHIN FUSOBACTERIUM-NUCLEATUM
    GHARBIA, SE
    SHAH, HN
    INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1992, 42 (02): : 296 - 298
  • [27] Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights
    Galasso, Linda
    Termite, Fabrizio
    Mignini, Irene
    Esposto, Giorgio
    Borriello, Raffaele
    Vitale, Federica
    Nicoletti, Alberto
    Paratore, Mattia
    Ainora, Maria Elena
    Gasbarrini, Antonio
    Zocco, Maria Assunta
    CANCERS, 2025, 17 (03)
  • [28] Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms
    Fan, Zixin
    Tang, Pengzhou
    Li, Cheng
    Yang, Qi
    Xu, Yan
    Su, Chuan
    Li, Lu
    JOURNAL OF ORAL MICROBIOLOGY, 2023, 15 (01)
  • [29] CHARACTERIZATION OF SHARED ANTIGENS OF FUSOBACTERIUM NUCLEATUM AND FUSOBACTERIUM-NECROPHORUM
    KAUR, M
    FALKLER, WA
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 1992, 7 (05): : 291 - 298
  • [30] Fusobacterium nucleatum, rectal cancer and radiotherapy
    Mann, E. H.
    Maughan, T. S.
    ANNALS OF ONCOLOGY, 2020, 31 (10) : 1277 - 1278